Reducing time to treatment is good for patients and the healthcare system
Physicians and patients don’t always agree on which outcomes are most important in cancer care. An example is the amount of time it takes to initiate treatment after a solid tumor diagnosis. Shortening the time-to-treat interval wouldn’t impact the medical outcome in the view of most oncologists, but to an anxious cancer patient, any wait is too long. And with medical value (and reimbursement) increasingly tied to delivery of patient-centered, timely care, the oncology community must embrace initiatives to quantify and improve these issues.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In this viewpoint article in the Journal of the National Comprehensive Cancer Network, Cleveland Clinic Taussig Cancer Institute Chairman Brian J. Bolwell, MD, and Vice-Chair for Clinical Services and Strategy Alok A. Khorana, MD, make the case for value-based, patient-focused cancer care and describe Cleveland Clinic Cancer Center’s initial efforts to shorten time to treatment using integrated practice techniques.
Photo Credit: ©Russell Lee
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients